Navigation Links
Study Highlights CyberKnife SBRT Benefits for Treatment of Central Lung Tumors
Date:1/26/2012

SUNNYVALE, Calif., Jan. 26, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today publication of a study demonstrating the benefits of the CyberKnife® Robotic Radiosurgery System in treating central lung tumors. Historically, the treatment of central lung tumors using gantry based Stereotactic Body Radiotherapy (SBRT) has been challenging and required a great deal of accuracy to avoid risks of damaging critical structures, such as the airway, esophagus and heart that can result in serious complications including death, leaving patients with fewer, less effective and sometimes only palliative options. This study, published in the January 2012 online issue of Radiotherapy & Oncology (commonly known as the Green Journal), demonstrated that the CyberKnife System, which leverages the Synchrony® Respiratory Tracking System and Lung Optimized Treatment to non-invasively track and correct for respiratory motion, allows clinicians to deliver lung SBRT to patients with central lung lesions with minimal toxicity, sparing surrounding healthy tissue, such as the esophagus, trachea and heart while also providing high levels of tumor control.

The study, "Outcome of Four-Dimensional Stereotactic Radiotherapy for Centrally Located Lung Tumors," reports on 56 patients (39 with primary lung cancer and 17 with metastatic tumors) treated with CyberKnife lung SBRT who were ineligible for surgery or chemotherapy, refused surgery or chemotherapy, or had an inoperable tumor. Local tumor control was 91 percent for the entire group at one year and 76 percent for the entire group at two years. The analysis of toxicity rates demonstrated that there were no serious complications reporting no acute grade three esophagitis, no grade four (life threa
'/>"/>

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... -- Uroplasty, Inc. (NASDAQ: UPI ), a medical device ... to treat voiding dysfunctions, today announced that it will ... March 10, 2015. Rob Kill , President and ... will present at 4:00 p.m. Pacific Time and meet ... the Ritz Carlton in Laguna Niguel, CA. ...
(Date:2/27/2015)... NEW YORK , Feb. 27, 2015 ... DESI are increasing in applications as their ... research firm Kalorama Information.  Kalorama Information says ... MS) is the most powerful tool in ... (mass spec; MS) through its traditional techniques ...
(Date:2/26/2015)... 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... the t:slim® and t:flex™ Insulin Pumps, today announced the ... of its common stock at a price to the ... Tandem from this offering are expected to be $56.3 ... estimated offering expenses payable by Tandem. All of the ...
Breaking Medicine Technology:Uroplasty to Participate in the 27th Annual ROTH Conference 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3
... Inc. (NASDAQ: DEPO ) today announced that ... Ironwood Pharmaceuticals, Inc. following the development and delivery of ... pre-specified attributes under its Research Collaboration and License Agreement ... 2011. Under the terms of the agreement, Depomed licensed to ...
... Challenged by weak demand in its domestic markets, Allied Healthcare Products ... third quarter of fiscal year 2012 on a decline in sales. ... a negative $146,000, or negative 2 cents per basic and diluted ... for the prior year. Sales for the quarter declined from about ...
Cached Medicine Technology:Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc. 2Allied Healthcare Products Reports Loss on Sales Decline 2Allied Healthcare Products Reports Loss on Sales Decline 3Allied Healthcare Products Reports Loss on Sales Decline 4
(Date:2/28/2015)... In a recent episode of ... Game Change Athlete Development Services and Consultancy talks ... of athlete development and player engagement during and after ... that athletes face and how off-field activities are a ... became involved in athlete development issues while in graduate ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 The Heart ... now a distributor of the machine. The Heart Fit ... their license, like a franchise model. The goal is ... and reverse heart disease. To buy External Counterpulsation ... Clinic can help individuals through this process and achieve ...
(Date:2/28/2015)... Vancouver, BC (PRWEB) February 28, 2015 ... has recently announced that they now provide business consulting ... services, such as corporate tax planning and succession planning. ... be entrusted to experienced professionals. On top of this, ... difficult to handle corporate accounting. As a result, Mew ...
(Date:2/28/2015)... CA (PRWEB) February 28, 2015 A ... a promising new gene therapy procedure for the treatment ... blindness in patients. Authored by Dr. Robert ... and published in the Lancet Medical Journal on January ... from choroideremia, a rare genetic disorder that mostly affects ...
(Date:2/28/2015)... Portland, OR (PRWEB) February 28, 2015 ... at the 2015 Japan Architecture & Construction Materials Show, ... They’ll join more than 1,000 suppliers and top manufacturers ... , Reclaimed wood products sourced and manufactured ... facilities have found popularity in Japan at restaurants, hotels, ...
Breaking Medicine News(10 mins):Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2
... Tips for Maintaining a Healthy Liver, NEW YORK, ... liver, the American Liver Foundation (ALF) today observed Liver,Awareness ... which affects,30 million Americans. Liver disease, a serious ... 7th leading cause of death among adults between the ...
... New research, published today in the Journal of American ... Health in Sydney, has found that lowering blood pressure ... strokes or heart attacks. Given the high risk of ... these results have significant implications for millions of people ...
... sessions free and open to public, top scientists will ... disorders and new directions in mental health ... methods of,understanding the human brain, involving sophisticated imaging and ... promise,better treatments for serious psychiatric illnesses. Some of the ...
... the largest non-government, not-for-profit funding source of cancer research in ... grants totaling more than $52.6 million in the first of ... new and 18 are renewals of previous grants. All of ... American Cancer Societys Research and Training Program has funded 40 ...
... Hands-Free Action Camera to Capture Exclusive Event Footage, ... one of the,world,s leading designers and marketers of ... the Love Hope,Strength Foundation as an official sponsor ... by 40 of the world,s top musicians and,mountaineers, ...
... Oct. 5 Anesiva,Inc. (Nasdaq: ANSV ) today ... will present at the Biotechnology Industry,Organization,s "BIO InvestorForum 2007" ... San Francisco. To access the live webcast or ... and go to the Investors page, and click on,Events. ...
Cached Medicine News:Health News:October is Liver Awareness Month: The American Liver Foundation Urges All Americans to Pay Attention to Their Liver Every Day of the Year 2Health News:October is Liver Awareness Month: The American Liver Foundation Urges All Americans to Pay Attention to Their Liver Every Day of the Year 3Health News:Double cardiovascular benefit for people with chronic kidney disease 2Health News:NARSAD - World's Leading Mental Health Research Charity - Presents 19th Annual New York Mental Health Symposium, Oct. 19th & 20th 2Health News:American Cancer Society awards research grants to 109 investigators at 77 institutions nationwide 2Health News:American Cancer Society awards research grants to 109 investigators at 77 institutions nationwide 3Health News:Oregon Scientific to Sponsor First-Ever Rock Concert on Mount Everest 2Health News:Oregon Scientific to Sponsor First-Ever Rock Concert on Mount Everest 3
... is a revolutionary motorized electronic pipette. ... mind, Pipetman Concept features exclusive multifunction ... only one of its kind in ... Tips from Gilson, this product will ...
HemoNIR™ is a portable device that measures the ability of apersons blood to carry oxygen by monitoring functional vs. non functional hemoglobin....
The Express Plus clinical chemistry analyzer is a fully automated walk away system designed for maximum productivity, convenience and reliability....
... The CIMScan System is ideally suited to ... are stored in hospitals and blood banks. ... to monitor various aspects of the physical ... distributed I/O components is handled over the ...
Medicine Products: